ZN451_HUMAN - dbPTM
ZN451_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZN451_HUMAN
UniProt AC Q9Y4E5
Protein Name E3 SUMO-protein ligase ZNF451 {ECO:0000303|PubMed:26524494}
Gene Name ZNF451
Organism Homo sapiens (Human).
Sequence Length 1061
Subcellular Localization Nucleus . Nucleus, PML body . Nucleus, nucleoplasm. Colocalizes with UBE2I/UBC9, SUMO1 and SUMO2 in nuclear granules
this probably requires sumoylation. Desumoylation leads to diffuse nucleoplasmic location.
Protein Description E3 SUMO-protein ligase; has a preference for SUMO2 and SUMO3 and facilitates UBE2I/UBC9-mediated sumoylation of target proteins. [PubMed: 26524493]
Protein Sequence MGDPGSEIIESVPPAGPEASESTTDENEDDIQFVSEGPLRPVLEYIDLVSSDDEEPSTSYTDENIKRKDHIDYQKDKVALTLARLARHVEVEKQQKEEKNRAFREKIDFQHAHGLQELEFIRGHSDTEAARLCVDQWLKMPGLKTGTINCGTKSSFRRGGHTWVSGKPILCPIMHCNKEFDNGHLLLGHLKRFDHSPCDPTITLHGPFFSSFACVVCYKKFVTQQQYRDHLFDKEATDDGHNNNLLPQIIQCFACPNCFLLFSRKEECSKHMSGKNHFHQSFKLGDNKGIAHPISFPSFAKKLLISLCKDVPFQVKCVACHKTLRSHMELTAHFRVHCRNAGPVAVAEKSITQVAEKFILRGYCPDCNQVFVDETSTQNHKQNSGHKVRVINSVEESVLLYCHSSEGNKDPSSDLHLLLDQSKFSSLKRTMSIKESSSLECIAIPKKKMNLKDKSHEGVACVQKEKSVVKTWFCECNQRFPSEDAVEKHVFSANTMGYKCVVCGKVCDDSGVIRLHMSRIHGGAHLNNFLFWCRTCKKELTRKDTIMAHVTEFHNGHRYFYEMDEVEGETLPSSSTTLDNLTANKPSSAITVIDHSPANSSPRGKWQCRICEDMFDSQEYVKQHCMSLASHKFHRYSCAHCRKPFHKIETLYRHCQDEHDNEIKIKYFCGLCDLIFNVEEAFLSHYEEHHSIDYVFVSEKTETSIKTEDDFPVIETSNQLTCGCRESYICKVNRKEDYSRCLQIMLDKGKLWFRCSLCSATAQNLTDMNTHIHQVHKEKSDEEEQQYVIKCGTCTKAFHDPESAQQHFHRKHCFLQKPSVAHFGSEKSNLYKFTASASHTERKLKQAINYSKSLDMEKGVENDLSYQNIEEEIVELPDLDYLRTMTHIVFVDFDNWSNFFGHLPGHLNQGTFIWGFQGGNTNWKPPLNCKIYNYLNRIGCFFLHPRCSKRKDAADFAICMHAGRLDEQLPKQIPFTILSGDQGFLELENQFKKTQRPAHILNPHHLEGDMMCALLNSISDTTKECDSDDNMGAKNTSIGEEFISTEDVELEEAIRRSLEEM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
45PhosphorylationPLRPVLEYIDLVSSD
CCCCCEEEEEECCCC
8.7927732954
50PhosphorylationLEYIDLVSSDDEEPS
EEEEEECCCCCCCCC
35.0320873877
51PhosphorylationEYIDLVSSDDEEPST
EEEEECCCCCCCCCC
41.4220873877
57PhosphorylationSSDDEEPSTSYTDEN
CCCCCCCCCCCCCCC
33.0127732954
58PhosphorylationSDDEEPSTSYTDENI
CCCCCCCCCCCCCCC
36.1527732954
59PhosphorylationDDEEPSTSYTDENIK
CCCCCCCCCCCCCCC
30.3027732954
60PhosphorylationDEEPSTSYTDENIKR
CCCCCCCCCCCCCCC
20.4927732954
61PhosphorylationEEPSTSYTDENIKRK
CCCCCCCCCCCCCCC
36.2827732954
68UbiquitinationTDENIKRKDHIDYQK
CCCCCCCCCCCCHHH
48.97-
75SumoylationKDHIDYQKDKVALTL
CCCCCHHHHHHHHHH
53.97-
75UbiquitinationKDHIDYQKDKVALTL
CCCCCHHHHHHHHHH
53.9721906983
75SumoylationKDHIDYQKDKVALTL
CCCCCHHHHHHHHHH
53.9728112733
75 (in isoform 1)Ubiquitination-53.9721890473
75 (in isoform 2)Ubiquitination-53.9721890473
77SumoylationHIDYQKDKVALTLAR
CCCHHHHHHHHHHHH
36.12-
77UbiquitinationHIDYQKDKVALTLAR
CCCHHHHHHHHHHHH
36.12-
77SumoylationHIDYQKDKVALTLAR
CCCHHHHHHHHHHHH
36.1228112733
77AcetylationHIDYQKDKVALTLAR
CCCHHHHHHHHHHHH
36.1225953088
81PhosphorylationQKDKVALTLARLARH
HHHHHHHHHHHHHHH
14.5024719451
93UbiquitinationARHVEVEKQQKEEKN
HHHHHHHHHHHHHHH
64.30-
96 (in isoform 4)Phosphorylation-66.4028348404
98 (in isoform 4)Phosphorylation-63.7728348404
100 (in isoform 4)Phosphorylation-43.7428348404
101 (in isoform 4)Phosphorylation-46.2828348404
102 (in isoform 4)Phosphorylation-19.7628348404
106SumoylationKNRAFREKIDFQHAH
HHHHHHHHCCHHHHC
43.23-
106UbiquitinationKNRAFREKIDFQHAH
HHHHHHHHCCHHHHC
43.2321890473
106SumoylationKNRAFREKIDFQHAH
HHHHHHHHCCHHHHC
43.2328112733
106 (in isoform 2)Ubiquitination-43.2321890473
106 (in isoform 1)Ubiquitination-43.2321890473
108 (in isoform 4)Phosphorylation-48.50-
111 (in isoform 4)Phosphorylation-21.4927135362
112 (in isoform 4)Phosphorylation-6.4027135362
121 (in isoform 4)Ubiquitination-3.6321906983
127PhosphorylationFIRGHSDTEAARLCV
ECCCCCCHHHHHHHH
30.45-
130 (in isoform 4)Ubiquitination-9.9521906983
138 (in isoform 4)Ubiquitination-2.5721906983
139SumoylationLCVDQWLKMPGLKTG
HHHHHHHCCCCCCCE
39.84-
139UbiquitinationLCVDQWLKMPGLKTG
HHHHHHHCCCCCCCE
39.84-
139SumoylationLCVDQWLKMPGLKTG
HHHHHHHCCCCCCCE
39.8428112733
144SumoylationWLKMPGLKTGTINCG
HHCCCCCCCEEEECC
51.31-
144UbiquitinationWLKMPGLKTGTINCG
HHCCCCCCCEEEECC
51.31-
144SumoylationWLKMPGLKTGTINCG
HHCCCCCCCEEEECC
51.3128112733
145PhosphorylationLKMPGLKTGTINCGT
HCCCCCCCEEEECCC
44.6024719451
147PhosphorylationMPGLKTGTINCGTKS
CCCCCCEEEECCCCC
17.7826434776
148 (in isoform 4)Phosphorylation-4.2026657352
149 (in isoform 4)Phosphorylation-20.2927050516
152PhosphorylationTGTINCGTKSSFRRG
CEEEECCCCCCCCCC
29.9226434776
153SumoylationGTINCGTKSSFRRGG
EEEECCCCCCCCCCC
29.41-
153UbiquitinationGTINCGTKSSFRRGG
EEEECCCCCCCCCCC
29.41-
153SumoylationGTINCGTKSSFRRGG
EEEECCCCCCCCCCC
29.4128112733
154PhosphorylationTINCGTKSSFRRGGH
EEECCCCCCCCCCCE
34.2526434776
155PhosphorylationINCGTKSSFRRGGHT
EECCCCCCCCCCCEE
25.0726434776
158MethylationGTKSSFRRGGHTWVS
CCCCCCCCCCEEEEC
54.1324129315
164 (in isoform 4)Ubiquitination-5.9321906983
167UbiquitinationGHTWVSGKPILCPIM
CEEEECCCEEEECEE
22.75-
167SumoylationGHTWVSGKPILCPIM
CEEEECCCEEEECEE
22.7528112733
171 (in isoform 4)Phosphorylation-1.9130631047
172 (in isoform 4)Phosphorylation-24.40-
173 (in isoform 4)Phosphorylation-2.6230631047
175 (in isoform 4)Phosphorylation-16.84-
191UbiquitinationHLLLGHLKRFDHSPC
CEEEHHHHHCCCCCC
45.40-
220SumoylationACVVCYKKFVTQQQY
EEEHHHHHCCCHHHH
20.70-
220SumoylationACVVCYKKFVTQQQY
EEEHHHHHCCCHHHH
20.70-
220UbiquitinationACVVCYKKFVTQQQY
EEEHHHHHCCCHHHH
20.70-
231 (in isoform 4)Phosphorylation-7.5125159151
240 (in isoform 4)Ubiquitination-28.3821906983
241 (in isoform 4)Phosphorylation-40.6225849741
247 (in isoform 4)Ubiquitination-26.8721906983
270SumoylationSRKEECSKHMSGKNH
ECHHHHHHHCCCCCC
55.7928112733
275AcetylationCSKHMSGKNHFHQSF
HHHHCCCCCCCCCCE
39.697962855
275SumoylationCSKHMSGKNHFHQSF
HHHHCCCCCCCCCCE
39.69-
275SumoylationCSKHMSGKNHFHQSF
HHHHCCCCCCCCCCE
39.6928112733
275UbiquitinationCSKHMSGKNHFHQSF
HHHHCCCCCCCCCCE
39.69-
283AcetylationNHFHQSFKLGDNKGI
CCCCCCEECCCCCCC
57.737962865
283SumoylationNHFHQSFKLGDNKGI
CCCCCCEECCCCCCC
57.73-
283UbiquitinationNHFHQSFKLGDNKGI
CCCCCCEECCCCCCC
57.73-
283SumoylationNHFHQSFKLGDNKGI
CCCCCCEECCCCCCC
57.7328112733
286 (in isoform 4)Ubiquitination-65.19-
288SumoylationSFKLGDNKGIAHPIS
CEECCCCCCCCCCCC
57.33-
288UbiquitinationSFKLGDNKGIAHPIS
CEECCCCCCCCCCCC
57.3321906983
288SumoylationSFKLGDNKGIAHPIS
CEECCCCCCCCCCCC
57.3328112733
288 (in isoform 2)Ubiquitination-57.3321890473
288 (in isoform 1)Ubiquitination-57.3321890473
293 (in isoform 4)Ubiquitination-18.20-
294 (in isoform 4)Ubiquitination-4.81-
301UbiquitinationISFPSFAKKLLISLC
CCCHHHHHHHHHHHH
41.78-
301SumoylationISFPSFAKKLLISLC
CCCHHHHHHHHHHHH
41.7828112733
302SumoylationSFPSFAKKLLISLCK
CCHHHHHHHHHHHHC
45.13-
302SumoylationSFPSFAKKLLISLCK
CCHHHHHHHHHHHHC
45.13-
302UbiquitinationSFPSFAKKLLISLCK
CCHHHHHHHHHHHHC
45.13-
308 (in isoform 4)Phosphorylation-2.5624114839
309UbiquitinationKLLISLCKDVPFQVK
HHHHHHHCCCCCEEE
68.03-
309SumoylationKLLISLCKDVPFQVK
HHHHHHHCCCCCEEE
68.0328112733
313 (in isoform 4)Ubiquitination-15.21-
316SumoylationKDVPFQVKCVACHKT
CCCCCEEEEECCCHH
16.53-
316UbiquitinationKDVPFQVKCVACHKT
CCCCCEEEEECCCHH
16.5321890473
316SumoylationKDVPFQVKCVACHKT
CCCCCEEEEECCCHH
16.53-
316AcetylationKDVPFQVKCVACHKT
CCCCCEEEEECCCHH
16.5325953088
316 (in isoform 1)Ubiquitination-16.5321890473
316 (in isoform 2)Ubiquitination-16.5321890473
333 (in isoform 4)Ubiquitination-13.0521906983
349UbiquitinationGPVAVAEKSITQVAE
CCEEEEEHHHHHHHH
37.1021906983
349 (in isoform 1)Ubiquitination-37.1021890473
349 (in isoform 2)Ubiquitination-37.1021890473
356 (in isoform 4)Ubiquitination-50.0421906983
357SumoylationSITQVAEKFILRGYC
HHHHHHHHHHHCCCC
28.15-
357UbiquitinationSITQVAEKFILRGYC
HHHHHHHHHHHCCCC
28.1521890473
357SumoylationSITQVAEKFILRGYC
HHHHHHHHHHHCCCC
28.1528112733
357 (in isoform 1)Ubiquitination-28.1521890473
357 (in isoform 2)Ubiquitination-28.1521890473
360 (in isoform 4)Phosphorylation-3.8025159151
361 (in isoform 4)Phosphorylation-29.2625159151
362 (in isoform 4)Phosphorylation-25.5825159151
369 (in isoform 4)Ubiquitination-36.04-
381UbiquitinationETSTQNHKQNSGHKV
CCCCCCCCCCCCCCE
59.74-
387UbiquitinationHKQNSGHKVRVINSV
CCCCCCCCEEEECCC
34.95-
401 (in isoform 4)Ubiquitination-5.51-
409UbiquitinationCHSSEGNKDPSSDLH
EECCCCCCCCCCCHH
80.17-
423SumoylationHLLLDQSKFSSLKRT
HHHHCHHHHHHCHHC
43.57-
423UbiquitinationHLLLDQSKFSSLKRT
HHHHCHHHHHHCHHC
43.5721890473
423SumoylationHLLLDQSKFSSLKRT
HHHHCHHHHHHCHHC
43.5728112733
423 (in isoform 1)Ubiquitination-43.5721890473
423 (in isoform 2)Ubiquitination-43.5721890473
428SumoylationQSKFSSLKRTMSIKE
HHHHHHCHHCCCCCC
48.01-
428SumoylationQSKFSSLKRTMSIKE
HHHHHHCHHCCCCCC
48.01-
430PhosphorylationKFSSLKRTMSIKESS
HHHHCHHCCCCCCCC
17.4329116813
432PhosphorylationSSLKRTMSIKESSSL
HHCHHCCCCCCCCCC
29.8725218447
434SumoylationLKRTMSIKESSSLEC
CHHCCCCCCCCCCEE
44.21-
434UbiquitinationLKRTMSIKESSSLEC
CHHCCCCCCCCCCEE
44.21-
434SumoylationLKRTMSIKESSSLEC
CHHCCCCCCCCCCEE
44.2128112733
436PhosphorylationRTMSIKESSSLECIA
HCCCCCCCCCCEEEE
21.8926434776
437PhosphorylationTMSIKESSSLECIAI
CCCCCCCCCCEEEEE
39.7826434776
438PhosphorylationMSIKESSSLECIAIP
CCCCCCCCCEEEEEE
37.1530622161
446SumoylationLECIAIPKKKMNLKD
CEEEEEECCCCCCCC
59.94-
446SumoylationLECIAIPKKKMNLKD
CEEEEEECCCCCCCC
59.9428112733
446UbiquitinationLECIAIPKKKMNLKD
CEEEEEECCCCCCCC
59.94-
448UbiquitinationCIAIPKKKMNLKDKS
EEEEECCCCCCCCCC
38.86-
452SumoylationPKKKMNLKDKSHEGV
ECCCCCCCCCCCCCE
59.09-
452SumoylationPKKKMNLKDKSHEGV
ECCCCCCCCCCCCCE
59.0928112733
452UbiquitinationPKKKMNLKDKSHEGV
ECCCCCCCCCCCCCE
59.09-
454SumoylationKKMNLKDKSHEGVAC
CCCCCCCCCCCCEEE
52.72-
454UbiquitinationKKMNLKDKSHEGVAC
CCCCCCCCCCCCEEE
52.7221906983
454SumoylationKKMNLKDKSHEGVAC
CCCCCCCCCCCCEEE
52.7228112733
454 (in isoform 1)Ubiquitination-52.7221890473
454 (in isoform 2)Ubiquitination-52.7221890473
464SumoylationEGVACVQKEKSVVKT
CCEEECCCCCHHEEE
46.87-
464UbiquitinationEGVACVQKEKSVVKT
CCEEECCCCCHHEEE
46.8721906983
464SumoylationEGVACVQKEKSVVKT
CCEEECCCCCHHEEE
46.8728112733
464 (in isoform 4)Phosphorylation-46.8730266825
464 (in isoform 1)Ubiquitination-46.8721890473
464 (in isoform 2)Ubiquitination-46.8721890473
465 (in isoform 4)Phosphorylation-33.2130266825
467 (in isoform 4)Phosphorylation-32.9830266825
470UbiquitinationQKEKSVVKTWFCECN
CCCCHHEEEEEEECC
37.57-
473 (in isoform 4)Ubiquitination-2.81-
488UbiquitinationPSEDAVEKHVFSANT
CCHHHHHHHCCCCCC
38.17-
490 (in isoform 4)Ubiquitination-6.3321906983
499SumoylationSANTMGYKCVVCGKV
CCCCCCCEEEEECCE
18.15-
499SumoylationSANTMGYKCVVCGKV
CCCCCCCEEEEECCE
18.15-
500 (in isoform 4)Ubiquitination-1.7721906983
505UbiquitinationYKCVVCGKVCDDSGV
CEEEEECCEECCCCC
34.27-
505 (in isoform 4)Ubiquitination-34.27-
522 (in isoform 4)Ubiquitination-32.39-
532 (in isoform 4)Ubiquitination-3.47-
537 (in isoform 4)Ubiquitination-48.98-
543SumoylationCKKELTRKDTIMAHV
CCHHHCCCCCEEHHE
54.72-
543SumoylationCKKELTRKDTIMAHV
CCHHHCCCCCEEHHE
54.7228112733
551PhosphorylationDTIMAHVTEFHNGHR
CCEEHHEEEEECCEE
24.0619690332
551 (in isoform 4)Phosphorylation-24.0624719451
557 (in isoform 4)Phosphorylation-26.95-
559PhosphorylationEFHNGHRYFYEMDEV
EEECCEEEEEEECEE
12.5827251275
561PhosphorylationHNGHRYFYEMDEVEG
ECCEEEEEEECEECC
11.0427251275
570PhosphorylationMDEVEGETLPSSSTT
ECEECCEECCCCCCC
55.6227251275
573PhosphorylationVEGETLPSSSTTLDN
ECCEECCCCCCCHHH
39.7827251275
574PhosphorylationEGETLPSSSTTLDNL
CCEECCCCCCCHHHC
29.7527251275
575PhosphorylationGETLPSSSTTLDNLT
CEECCCCCCCHHHCC
29.7427251275
576PhosphorylationETLPSSSTTLDNLTA
EECCCCCCCHHHCCC
33.0727251275
577PhosphorylationTLPSSSTTLDNLTAN
ECCCCCCCHHHCCCC
33.7827251275
582PhosphorylationSTTLDNLTANKPSSA
CCCHHHCCCCCCCCC
34.1427251275
585UbiquitinationLDNLTANKPSSAITV
HHHCCCCCCCCCEEE
43.7621906983
585 (in isoform 2)Ubiquitination-43.7621890473
585SumoylationLDNLTANKPSSAITV
HHHCCCCCCCCCEEE
43.7628112733
585 (in isoform 1)Ubiquitination-43.7621890473
587PhosphorylationNLTANKPSSAITVID
HCCCCCCCCCEEEEE
33.7327251275
588PhosphorylationLTANKPSSAITVIDH
CCCCCCCCCEEEEEC
32.0227251275
591PhosphorylationNKPSSAITVIDHSPA
CCCCCCEEEEECCCC
15.8926074081
596PhosphorylationAITVIDHSPANSSPR
CEEEEECCCCCCCCC
23.2025159151
600PhosphorylationIDHSPANSSPRGKWQ
EECCCCCCCCCCCCE
43.7725849741
601PhosphorylationDHSPANSSPRGKWQC
ECCCCCCCCCCCCEE
20.5825849741
605SumoylationANSSPRGKWQCRICE
CCCCCCCCCEEEECH
35.06-
605SumoylationANSSPRGKWQCRICE
CCCCCCCCCEEEECH
35.06-
622UbiquitinationFDSQEYVKQHCMSLA
CCCHHHHHHHHHHHH
33.16-
632SumoylationCMSLASHKFHRYSCA
HHHHHHHHHHHCCCH
40.13-
632SumoylationCMSLASHKFHRYSCA
HHHHHHHHHHHCCCH
40.1328112733
632UbiquitinationCMSLASHKFHRYSCA
HHHHHHHHHHHCCCH
40.13-
647SumoylationHCRKPFHKIETLYRH
HCCCCHHHHHHHHHH
42.49-
647SumoylationHCRKPFHKIETLYRH
HCCCCHHHHHHHHHH
42.4928112733
647UbiquitinationHCRKPFHKIETLYRH
HCCCCHHHHHHHHHH
42.49-
664SumoylationDEHDNEIKIKYFCGL
CCCCCCEEHHHHHHH
27.28-
664UbiquitinationDEHDNEIKIKYFCGL
CCCCCCEEHHHHHHH
27.28-
664SumoylationDEHDNEIKIKYFCGL
CCCCCCEEHHHHHHH
27.2828112733
706SumoylationEKTETSIKTEDDFPV
CCCCCCCCCCCCCCE
45.70-
706UbiquitinationEKTETSIKTEDDFPV
CCCCCCCCCCCCCCE
45.7021906983
706SumoylationEKTETSIKTEDDFPV
CCCCCCCCCCCCCCE
45.7025114211
706 (in isoform 1)Ubiquitination-45.7021890473
706 (in isoform 2)Ubiquitination-45.7021890473
731SumoylationCRESYICKVNRKEDY
CCCEEEEECCCCCCH
32.74-
731UbiquitinationCRESYICKVNRKEDY
CCCEEEEECCCCCCH
32.74-
731SumoylationCRESYICKVNRKEDY
CCCEEEEECCCCCCH
32.7428112733
731AcetylationCRESYICKVNRKEDY
CCCEEEEECCCCCCH
32.7425953088
735UbiquitinationYICKVNRKEDYSRCL
EEEECCCCCCHHHHH
50.13-
748UbiquitinationCLQIMLDKGKLWFRC
HHHHHHCCCCEEEEE
54.72-
748SumoylationCLQIMLDKGKLWFRC
HHHHHHCCCCEEEEE
54.7228112733
750SumoylationQIMLDKGKLWFRCSL
HHHHCCCCEEEEEHH
48.57-
750SumoylationQIMLDKGKLWFRCSL
HHHHCCCCEEEEEHH
48.57-
750UbiquitinationQIMLDKGKLWFRCSL
HHHHCCCCEEEEEHH
48.57-
777SumoylationTHIHQVHKEKSDEEE
HHHHHHHHHCCCHHH
68.9028112733
779SumoylationIHQVHKEKSDEEEQQ
HHHHHHHCCCHHHHE
68.93-
779UbiquitinationIHQVHKEKSDEEEQQ
HHHHHHHCCCHHHHE
68.9321906983
779SumoylationIHQVHKEKSDEEEQQ
HHHHHHHCCCHHHHE
68.9328112733
779 (in isoform 2)Ubiquitination-68.9321890473
779 (in isoform 1)Ubiquitination-68.9321890473
790SumoylationEEQQYVIKCGTCTKA
HHHEEEEEECCCCHH
19.30-
790UbiquitinationEEQQYVIKCGTCTKA
HHHEEEEEECCCCHH
19.30-
790SumoylationEEQQYVIKCGTCTKA
HHHEEEEEECCCCHH
19.3028112733
790 (in isoform 2)Ubiquitination-19.30-
796UbiquitinationIKCGTCTKAFHDPES
EEECCCCHHHCCHHH
51.72-
811SumoylationAQQHFHRKHCFLQKP
HHHHHHHHCCCCCCC
35.83-
811SumoylationAQQHFHRKHCFLQKP
HHHHHHHHCCCCCCC
35.83-
811UbiquitinationAQQHFHRKHCFLQKP
HHHHHHHHCCCCCCC
35.83-
817SumoylationRKHCFLQKPSVAHFG
HHCCCCCCCCEEECC
41.21-
817SumoylationRKHCFLQKPSVAHFG
HHCCCCCCCCEEECC
41.2128112733
817UbiquitinationRKHCFLQKPSVAHFG
HHCCCCCCCCEEECC
41.21-
817AcetylationRKHCFLQKPSVAHFG
HHCCCCCCCCEEECC
41.2126051181
819PhosphorylationHCFLQKPSVAHFGSE
CCCCCCCCEEECCCC
38.6830576142
825PhosphorylationPSVAHFGSEKSNLYK
CCEEECCCCCCCEEE
40.6925159151
827SumoylationVAHFGSEKSNLYKFT
EEECCCCCCCEEEEE
46.47-
827UbiquitinationVAHFGSEKSNLYKFT
EEECCCCCCCEEEEE
46.4721890473
827SumoylationVAHFGSEKSNLYKFT
EEECCCCCCCEEEEE
46.4728112733
827 (in isoform 2)Ubiquitination-46.4721890473
827 (in isoform 1)Ubiquitination-46.4721890473
831PhosphorylationGSEKSNLYKFTASAS
CCCCCCEEEEECCCC
14.33-
832SumoylationSEKSNLYKFTASASH
CCCCCEEEEECCCCC
39.13-
832UbiquitinationSEKSNLYKFTASASH
CCCCCEEEEECCCCC
39.1321890473
832SumoylationSEKSNLYKFTASASH
CCCCCEEEEECCCCC
39.1328112733
832 (in isoform 2)Ubiquitination-39.1321890473
832 (in isoform 1)Ubiquitination-39.1321890473
834PhosphorylationKSNLYKFTASASHTE
CCCEEEEECCCCCHH
18.6230576142
836PhosphorylationNLYKFTASASHTERK
CEEEEECCCCCHHHH
27.5229449344
838PhosphorylationYKFTASASHTERKLK
EEEECCCCCHHHHHH
28.5729116813
840PhosphorylationFTASASHTERKLKQA
EECCCCCHHHHHHHH
34.6830576142
843SumoylationSASHTERKLKQAINY
CCCCHHHHHHHHHHH
54.53-
843SumoylationSASHTERKLKQAINY
CCCCHHHHHHHHHHH
54.5328112733
843UbiquitinationSASHTERKLKQAINY
CCCCHHHHHHHHHHH
54.53-
845SumoylationSHTERKLKQAINYSK
CCHHHHHHHHHHHHH
40.49-
845UbiquitinationSHTERKLKQAINYSK
CCHHHHHHHHHHHHH
40.4921906983
845SumoylationSHTERKLKQAINYSK
CCHHHHHHHHHHHHH
40.4928112733
845 (in isoform 2)Ubiquitination-40.4921890473
845 (in isoform 1)Ubiquitination-40.4921890473
850PhosphorylationKLKQAINYSKSLDME
HHHHHHHHHHCCCCC
16.0330576142
852SumoylationKQAINYSKSLDMEKG
HHHHHHHHCCCCCCC
44.68-
852UbiquitinationKQAINYSKSLDMEKG
HHHHHHHHCCCCCCC
44.6821890473
852SumoylationKQAINYSKSLDMEKG
HHHHHHHHCCCCCCC
44.6828112733
852 (in isoform 2)Ubiquitination-44.6821890473
852 (in isoform 1)Ubiquitination-44.6821890473
853PhosphorylationQAINYSKSLDMEKGV
HHHHHHHCCCCCCCC
24.5424719451
858UbiquitinationSKSLDMEKGVENDLS
HHCCCCCCCCCCCCC
62.71-
944 (in isoform 2)Ubiquitination-11.5521890473
951UbiquitinationHPRCSKRKDAADFAI
CCCCCCCCCHHHHHH
56.29-
951SumoylationHPRCSKRKDAADFAI
CCCCCCCCCHHHHHH
56.2928112733
971UbiquitinationRLDEQLPKQIPFTIL
CCCCCCCCCCCEEEE
70.25-
992SumoylationLELENQFKKTQRPAH
HHHHHHHHHCCCCHH
45.18-
992UbiquitinationLELENQFKKTQRPAH
HHHHHHHHHCCCCHH
45.182190698
992SumoylationLELENQFKKTQRPAH
HHHHHHHHHCCCCHH
45.1828112733
992 (in isoform 1)Ubiquitination-45.1821890473
993UbiquitinationELENQFKKTQRPAHI
HHHHHHHHCCCCHHH
51.70-
993SumoylationELENQFKKTQRPAHI
HHHHHHHHCCCCHHH
51.7028112733
1023UbiquitinationNSISDTTKECDSDDN
HHHCCCCCCCCCCCC
59.44-
1027PhosphorylationDTTKECDSDDNMGAK
CCCCCCCCCCCCCCC
59.5323401153
1034UbiquitinationSDDNMGAKNTSIGEE
CCCCCCCCCCCCCCC
55.84-
1036PhosphorylationDNMGAKNTSIGEEFI
CCCCCCCCCCCCCCC
22.4828348404
1037PhosphorylationNMGAKNTSIGEEFIS
CCCCCCCCCCCCCCC
37.6829496963

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ZN451_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZN451_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZN451_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ANDR_HUMANARphysical
18656483
MPP5_HUMANMPP5physical
23718855
KDM1A_HUMANKDM1Aphysical
23455924
JMJD6_HUMANJMJD6physical
23455924
ANM1_HUMANPRMT1physical
23455924
ANM8_HUMANPRMT8physical
23455924
SUV91_HUMANSUV39H1physical
23455924
ZN451_HUMANZNF451physical
18656483
UBC9_HUMANUBE2Iphysical
18656483
PIAS1_HUMANPIAS1physical
18656483
PIAS2_HUMANPIAS2physical
18656483
F118A_HUMANFAM118Aphysical
21516116
CDCA4_HUMANCDCA4physical
21516116
UBC9_HUMANUBE2Iphysical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZN451_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP